Hiroaki Hata

Dr. Hiroaki Hata

orcid

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in IDCases
Verified
Journal Article
Open access
KFKohei Fujita
Kohei Fujita
OKOsamu Kanai
Osamu Kanai
KNKazutaka Nanba
Kazutaka Nanba
NENaoki Esaka
Naoki Esaka
HHHiroaki Hata
Hiroaki Hata
TOTakao Odagaki
Takao Odagaki
The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is having serious medical, social, and economic impacts worldwide. COVID-19 may lead to a variety of complications, including rhabdomyolysis. Although rhabdomyolysis is a rare complication, it can lead to severe kidney damage. Recent studies suggest that rhabdomyolysis caused by SARS-CoV-2 is more common in middle-aged and older men with severe COVID-19. Herein we report a case of rhabdomyolysis in a young woman with moderate COVID-19. She had a habit of muscle training. She presented with moderate COVID-19 and acute rhabdomyolysis that required a large volume of fluid infusion in addition to dexamethasone and remdesivir. Clinicians should pay attention to the development of rhabdomyolysis in patients with COVID-19, especially those with a habit of strenuous exercise or muscle training, even if they are young and have moderate COVID-19.

1 September 1998 in The Japanese Journal of Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
PDF file
YOYukihiko Orime
Yukihiko Orime
MSMotomi Shiono
Motomi Shiono
HHHiroaki Hata
Hiroaki Hata
SYShinya Yagi
Shinya Yagi
STSaeki Tsukamoto
Saeki Tsukamoto
YSYukiyasu Sezai
Yukiyasu Sezai

6 June 2020 in World Journal of Surgery
Verified
Journal Article
Open access
PDF file
HYHiroshi Yabusaki
Hiroshi Yabusaki
YKYasuhiro Kodera
Yasuhiro Kodera
NFNorimasa Fukushima
Norimasa Fukushima
NHNaoki Hiki
Naoki Hiki
SKShinichi Kinami
Shinichi Kinami
KNKoji Nakada
Koji Nakada
Background Proximal gastrectomy (PG) has become an increasingly preferred procedure for early cancer in the upper third of the stomach, owing to reportedly superior quality of life (QOL) after PG when compared with total gastrectomy. However, various methods of reconstruction have currently been proposed. We compared the postoperative QOL among the three different reconstruction methods after PG using the Postgastrectomy Syndrome Assessment Scale-45 (PGSAS-45) questionnaire. Methods Post Gastrectomy Syndrome Assessment Study (PGSAS), a nationwide multi-institutional survey, was conducted to evaluate QOL using the PGSAS-45 among various types of gastrectomy. Of the 2,368 eligible data from the PGSAS survey, data from 193 patients who underwent PG were retrieved and used in the current study. The PGSAS-45 consists of 45 items including 22 original gastrectomy specific items in addition to the SF-8 and GSRS. These were consolidated into 19 main outcome measures pertaining postgastrectomy symptoms, amount of food ingested, quality of ingestion, work, and level of satisfaction for daily work, and the three reconstruction methods (n = 193; 115 esophago-gastrostomy [PGEG], 34 jejunal interposition [PGJI], and 44 jejunal pouch interposition [PGJPI]) were compared using PGSAS-45. Results Size of the remnant stomach was significantly larger in PGEG, and significantly smaller in PGJI and PGJPI (P < 0.05). There was no difference in other patient background factors among the groups. EGJPI tended to be superior to PGEG in several of the 19 main outcome with marginal significance (P = 0.047–0.076). Conclusion PGJPI appears to be the most favorable of the three reconstruction methods after PG especially when the size of remnant stomach is rather small. Trial registration number UMIN-CTR #000002116 entitled as “A study to observe correlation between resection and reconstruction procedures employed for gastric neoplasms and development of postgastrectomy syndrome”

1 January 2014 in Annals of Thoracic and Cardiovascular Surgery
Verified
Journal Article
Open access
PDF file
ASAkira Sezai
Akira Sezai
KNKin-Ichi Nakata
Kin-Ichi Nakata
MIMitsuru Iida
Mitsuru Iida
Isamu YoshitakeIsamu Yoshitake
Isamu Yoshitake
SWShinji Wakui
Shinji Wakui
MSMotomi Shiono
Motomi Shiono
Background: Chronic kidney disease (CKD) is an important risk factor for cardiac surgery. In the most recently reported NU-HIT trial for CKD with CKD patients underwent coronary artery bypass grafting (CABG) as subjects, carperitide was reported to be effective in terms of renal function. In the present study, a subanalysis was performed on patients registered in the NU-HIT trial for CKD from the standpoint of renin-angiotensin system, natriuresis and renal function. Methods: 303 patients with CKD who underwent isolated CABG were divided into a group that received carperitide infusion and another group without carperitide. The renin activity, angiotensin-II, aldosterone, urine-sodium, urine- creatinine, fractional sodium excretion, renal failure index, and BNP levels. Results: There were significant lower in hANP group than the placebo group, in angiotensin-II at one day postoperatively, and in aldosterone from 0 day to one month postoperatively. FENa was significantly lower in the hANP group at 3 day and one week postoperatively. Conclusions: In on pump isolated CABG patients with CKD, carperitide showed a potent natriuretic action and inhibited the renin-angiotensin system, suggesting that it prevented deterioration of postoperative renal function. Our findings raise new possibilities for the perioperative and postoperative management of patients undergoing surgery with cardiopulmonary bypass.

19 May 2020 in medRxiv
Verified
Preprint
Open access
PDF file
KFKohei Fujita
Kohei Fujita
SKShinpei Kada
Shinpei Kada
OKOsamu Kanai
Osamu Kanai
HHHiroaki Hata
Hiroaki Hata
TOTakao Odagaki
Takao Odagaki
AYAkihiro Yasoda
Akihiro Yasoda
Background: The coronavirus disease-2019 (COVID-19) pandemic is associated with a heavy burden on the mental and physical health of patients, regional healthcare resources, and global economic activity. While our understanding of the incidence and case-fatality rates increases, data on seroprevalence of antibodies against the severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) in healthcare workers during the peri-pandemic period is insufficient. This study quantitatively evaluated seroprevalence of SARS-CoV-2 antibody in healthcare workers in the southern part of Kyoto city, Japan. Methods: We prospectively recruited healthcare workers from a single hospital between April 10 and April 20, 2020. We collected serum samples from these participants and quantitatively evaluated SARS-CoV-2 IgG antibody levels by enzyme-linked immunosorbent assay. Results: Five (5.4%), 15 (16.3%), and 72 (78.3%) participants showed positive, borderline, and negative serum SARS-CoV-2 IgG antibody status, respectively. We found the mean titer associated with each antibody status (overall, positive, borderline, and negative) was clearly differentiated. Participants working at the otolaryngology department and/or having a history of seasonal common cold symptoms had a significantly higher titer of SARS-CoV-2 IgG antibody (p=0.046, p=0.046, respectively). Conclusions: Five (5.4%) and 15 (16.3%) participants tested positive and borderline, respectively, for SARS-CoV-2 IgG antibody during the COVID-19 peri-pandemic period. These rates were higher than expected based on government situation reports. The present findings suggest that COVID-19 was already spread in the southern part of Kyoto city at the early stage of pandemic.

1 January 2015 in The Japanese Journal of Gastroenterological Surgery
Verified
Journal Article
Open access
PDF file
KHKeita Hanada
Keita Hanada
HHHiroaki Hata
Hiroaki Hata
SKShiori Kikuchi
Shiori Kikuchi
HNHiroki Nakanishi
Hiroki Nakanishi
MSMasashi Saji
Masashi Saji
IIIwao Ikai
Iwao Ikai
総合学術電子ジャーナルサイト「J-STAGE」-国内で発行された学術論文全文を読むことのできる、日本最大級の総合電子ジャーナルプラットフォームです。